Last kr276.00 DKK
Change Today +0.30 / 0.11%
Volume 385.3K
NZYMB On Other Exchanges
Symbol
Exchange
OTC US
Copenhagen
Frankfurt
As of 11:02 AM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - NOVOZYMES A/S-B SHARES (NZYMB)

Novozymes A/S to Report Fiscal Year 2015 on Jan 19, 2016
CapIQ 01/19/2016 5:00 AM ET
Novozymes A/S to Report Nine Months, 2015 on Oct 22, 2015
CapIQ 01/19/2016 5:00 AM ET
Novozymes A/S to Report First Half, 2015 on Aug 06, 2015
CapIQ 01/19/2016 5:00 AM ET

2013 revenues at Novozymes A/S totaled kr11.7B DKK, while annual earnings equaled kr6.93 per share.

Quarterly Earnings & Estimates - NOVOZYMES A/S-B SHARES (NZYMB)

Actuals vs. Estimates for NOVOZYMES A/S-B SHARES NZYMB

Novozymes A/S's Quarterly Earnings

Novozymes A/S reported 1st quarter 2014 earnings of kr2.18 per share on 04/26/2014.

Annual Earnings & Estimates - NOVOZYMES A/S-B SHARES (NZYMB)

Actuals vs. Estimates for NOVOZYMES A/S-B SHARES NZYMB

Novozymes A/S's Annual Earnings

Novozymes A/S reported annual 2013 earnings of kr6.93 per share on 01/23/2014.

Quarterly Revenues - NOVOZYMES A/S-B SHARES (NZYMB)

Actuals vs. Estimates for NOVOZYMES A/S-B SHARES NZYMB

Novozymes A/S's Quarterly Revenues

Novozymes A/S had 1st quarter 2014 revenues of kr3.0B DKK. This bettered the kr3.0B DKK consensus of the 7 analysts covering the company. This was 6.6% above the prior year's 1st quarter results.

Annual Revenues - NOVOZYMES A/S-B SHARES (NZYMB)

Actuals vs. Estimates for NOVOZYMES A/S-B SHARES NZYMB

Novozymes A/S's Annual Revenues

Novozymes A/S had revenues for the full year 2013 of kr11.7B DKK. This was 4.6% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NZYMB:DC kr276.00 DKK +0.30

NZYMB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chr Hansen Holding A/S kr255.60 DKK +4.70
Ebro Foods SA €14.79 EUR +0.12
EMS-Chemie Holding AG SFr.354.75 CHF +4.75
Kerry Group PLC €56.58 EUR +1.27
View Industry Companies
 

Industry Analysis

NZYMB

Industry Average

Valuation NZYMB Industry Range
Price/Earnings 34.5x
Price/Sales 6.9x
Price/Book 7.6x
Price/Cash Flow 29.0x
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVOZYMES A/S-B SHARES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.